Osborne Clarke advises King's College London on formation of Cytolytix Limited with ValiRx PLC to develop triple negative breast cancer treatment
International law practice Osborne Clarke has advised King's College London on its establishment with ValiRx PLC ("ValiRx") of Cytolytix Limited...
Published on
07/11/2022
Read time
1m